Swedish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

ginsenoside m 3/neoplasms

Länken sparas på Urklipp
10 resultat

Composition for preventing or treating liver cancer containing ginsenoside F2

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
This application claims the benefit of Korean Patent Application No 10-2016-0099978, filed Aug. 5, 2016, the entirety of which is incorporated herein by reference. TECHNICAL FIELD The present invention relates to a pharmaceutical composition for preventing or treating liver cancer containing
CROSS REFERENCE TO RELATED APPLICATIONS This application is a 35 U.S.C. .sctn. 371 National Phase Entry Application from PCT/KR2013/007852, filed on Aug. 30, 2013, and designating the United States, which is incorporated herein by reference in its entirety. TECHNICAL FIELD The present invention

Ginsenoside with anti-cancer activity and the preparation method thereof

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF INVENTION This invention relates to a novel ginsenoside compound derived from ginsenoside Rh2, the preparation methods and the use thereof in treating cancers. BACKGROUND OF INVENTION In the past decades, a number of anti-cancer drugs have been discovered from natural products, which

Ginsenoside chemotherapy

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION The invention is in the field of therapeutic compositions and methods, particularly chemotherapy of cancer using ginsenosides. BACKGROUND OF THE INVENTION Panax ginseng has served as an important component of traditional Chinese medicine for thousands of years. Recently,

Method for preparing processed ginseng to obtain increased amount of ginsenoside RG5

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
This application claims priority upon Korean. Patent application Ser. No. KR 10-2005-00305 19 filed on Apr. 12, 2005, the contents of which are all herein incorporated by this reference in their entireties. All publications, patents, patent applications, databases and other references cited in this
TECHNICAL FIELD The invention belongs to the field of medicines, and relates to a medicine or health food for treating human cytomegalovirus infection, particularly to application of ginseng (a traditional Chinese medicine) extracts and derivatives thereof in medicines or health foods for treating

Water solution of 20(R)-ginsenoside Rg3 pharmaceutical composition and process thereof

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
TECHNOLOGICAL FIELD OF THE INVENTION This invention relates to a ginsenoside Rg3 pharmaceutical composition and process thereof. TECHNOLOGICAL BACKGROUND OF THE INVENTION Ginsenoside Rg3 is a tetracyclic-triterpene saponin compound existed in Ginseng, with a molecular weight of 784.13. There are two

Aqueous solution of 20(R)-ginsenoside RG3 pharmaceutical composition and process thereof

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
TECHNOLOGICAL FIELD OF THE INVENTION This invention relates to a ginsenoside Rg3 pharmaceutical composition and process thereof. TECHNOLOGICAL BACKGROUND OF THE INVENTION Ginsenoside Rg3 is a tetracyclic-triterpene saponin compound existed in Ginseng, with a molecular weight of 784.13. There are two

20(R)-ginsenoside Rg3 polyacylated derivatives, preparation and application thereof

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
This application is the U.S. National phase application corresponding to PCT/CN2014/094726 which was assigned an international filing date of Dec. 23, 2014 and associated with publication WO 2016/095249 A1 and which claims priority to Chinese Application 2014107851724 filed on Dec. 17, 2014, the

Anticancer adjuvant containing panaxadiol ginsenocide compound

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
CROSS REFERENCE TO RELATED APPLICATIONS This application is a U.S. National Stage Application filed under 35 U.S.C. .sctn. 371 and claims priority to International Application No. PCT/KR2015/006832, filed Jul. 2, 2015, which application claims priority to Korean Application No. 10-2015-0071477,
Gå med på vår
facebook-sida

Den mest kompletta databasen med medicinska örter som stöds av vetenskapen

  • Fungerar på 55 språk
  • Växtbaserade botemedel som stöds av vetenskap
  • Örter igenkänning av bild
  • Interaktiv GPS-karta - märka örter på plats (kommer snart)
  • Läs vetenskapliga publikationer relaterade till din sökning
  • Sök efter medicinska örter efter deras effekter
  • Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent

Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot.
* All information baseras på publicerad vetenskaplig forskning

Google Play badgeApp Store badge